ArticleFrontiers in medicine2023

Peginterferon lambda for the treatment of hospitalized patients with mild COVID-19: A pilot phase 2 randomized placebo-controlled trial.

Myung-Ho Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.